| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 07/15/1999 | CA2317644A1 Anti-fungal compositions with prolonged activity |
| 07/15/1999 | CA2317453A1 Pharmaceutical compositions and method of using same |
| 07/14/1999 | EP0928207A1 Adhesive agent and use of such agent |
| 07/14/1999 | EP0928196A1 Beta-glucan products and extraction processes from cereals |
| 07/14/1999 | EP0928189A1 Delivery of biologically active material in a liposomal formulation for administration into the mouth |
| 07/14/1999 | EP0735892B1 Laxative compositions containing bulk fiber and dioctyl sulfosuccinate |
| 07/14/1999 | CN1222385A Reverse transcriptase inhibitor |
| 07/13/1999 | USRE36253 Jojoba oil, a cosmetic oil and tolnaftate for treating fungal infections of nails, including sculptured nails and cuticles |
| 07/13/1999 | US5922766 Palatable elemental medical food |
| 07/13/1999 | US5922331 Skin cream composition |
| 07/13/1999 | CA2162249C Cholesterol lowering drink mix compositions |
| 07/13/1999 | CA2148074C Cosmetic or pharmaceutical composition for topical use |
| 07/08/1999 | WO1999033939A1 Barley malt oil containing vegetable ceramide-associated substances and process for producing the same |
| 07/08/1999 | WO1999033872A1 Novel anti-hiv immunogens (toxoids), preparation methods and use for preventing and treating aids |
| 07/08/1999 | WO1999033480A1 Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection |
| 07/08/1999 | WO1999033363A1 Bilberry-containing drinks and process for producing the same |
| 07/08/1999 | WO1999033346A1 Anti-retroviral immunogens, preparation and use |
| 07/08/1999 | WO1999021006A9 Pharmaceutical grade valerian, black cohosh, vitex agnus-castus, bilberry and milk thistle |
| 07/08/1999 | WO1999020291A3 Pharmaceutical grade ginkgo biloba |
| 07/08/1999 | DE19800330A1 Preparation of pharmaceutically active carbon dioxide extract from Tanacetum parthenium |
| 07/08/1999 | CA2354409A1 Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection |
| 07/08/1999 | CA2316811A1 Anti-retroviral immunogens, preparation and use |
| 07/07/1999 | EP0926956A1 Use of algae extract as antibacterial and/or antifungal agent and composition containing same |
| 07/07/1999 | CN1221604A Hair treatment composition and method of manufacturing the composition |
| 07/06/1999 | US5919464 Controlling cell differentiation |
| 07/06/1999 | US5919460 Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome |
| 07/06/1999 | US5919291 Liquid extracted from at least one type of malvaceae, orchidaceae and aloe is used as the water-soluble fungusproofing agent. |
| 07/01/1999 | WO1999032205A1 Processes for forming stabilized biochemical agricultural products |
| 07/01/1999 | WO1999032131A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/01/1999 | WO1999032130A1 Medicinal plant dry extracts |
| 07/01/1999 | WO1999032129A1 Ginkgo biloba leaf extracts with a reduced 4'-o-methylpyridoxine and biflavone content |
| 07/01/1999 | WO1999032099A2 Use of fucane for regulating the reconstruction of connective tissues |
| 07/01/1999 | WO1999021009A9 Pharmaceutical grade saw palmetto, serenoa repens |
| 07/01/1999 | WO1999015167A3 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 07/01/1999 | DE19756848A1 Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen Extracts from leaves of Ginkgo biloba with a reduced content of 4'-O-methyl and biflavones |
| 06/30/1999 | EP0925057A1 Bowman-birk inhibitor for male sexual dysfunction |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | CN1221317A Host-derived signals for inducing isoprenoid gene expression and uses thereof |
| 06/29/1999 | US5917052 Hypoglycemic agent from cryptolepis |
| 06/29/1999 | US5916579 Process for combating adiposity and compositions which may be used for this purpose |
| 06/29/1999 | US5916577 Cosmetic with condensates of plant and animal decomposition products |
| 06/29/1999 | US5916576 Orange extract obtained from orange peel, orange flowers or orange leaves and contains less than 1% ascorbic acid; anti-radical activity towards superoxide radical; antiaging agent; cosmetics |
| 06/29/1999 | US5916573 Topical treatment of the skin with a grapeseed oil composition |
| 06/29/1999 | US5916567 Powdered inner seed and powdered fibrous outer shell subjected to radiation |
| 06/29/1999 | US5916566 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| 06/29/1999 | US5916565 Antiarthritic agent consists of a palatability agent, cayenne, ginger, yucca roots, devil's claw, black cohosh, nettle leaf, tumeric, alfalfa, celery seeds, glucosamine hydrochlorie and mucopolysaccharide |
| 06/29/1999 | US5916564 Tripterygium wilfordii Hook F extracts and components thereof for immunosuppression |
| 06/29/1999 | US5916555 Pharmaceutical composition for treatment of diabetes |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030725A1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 06/24/1999 | WO1999030701A1 Method of the prophylactic treatment of mastitis |
| 06/24/1999 | WO1999030682A1 Novel antioxidant mixture |
| 06/24/1999 | DE19758090A1 Composition comprising Actinidia arguta, useful in pharmaceuticals and cosmetics |
| 06/24/1999 | DE19756677A1 Per-oral dry plant extract |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/23/1999 | EP0923938A1 Immunopotentiators |
| 06/23/1999 | EP0923937A2 A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders |
| 06/23/1999 | EP0923936A2 Flavor-improved extract from Cassia mimosoides L. var. nomame Makino and method of preparing the same |
| 06/23/1999 | CN1220607A Immunopotentiators |
| 06/23/1999 | CN1220164A Extracts from crude drugs |
| 06/23/1999 | CA2254418A1 A highly concentrated mineralised natural complex for the integration of mineral oligoelements and method for its production |
| 06/22/1999 | CA2254347A1 Processes for forming stabilized liquid biochemical agricultural products |
| 06/17/1999 | WO1999029333A1 Compositions and methods for weight reduction |
| 06/17/1999 | WO1999029332A1 Compositions for weight reduction |
| 06/17/1999 | WO1999029331A1 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents |
| 06/17/1999 | WO1999029313A1 Method of increasing the production and improving the quality of semen |
| 06/17/1999 | DE19754940A1 Preparation and administration of plant extracts |
| 06/16/1999 | EP0848736A4 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 06/16/1999 | EP0789513A4 Improved stability of azadirachtin-containing solid |
| 06/16/1999 | EP0633764B1 Skin care method and composition |
| 06/16/1999 | EP0581842B1 An organ specific emulsion |
| 06/16/1999 | CN1219880A Acne treatment |
| 06/16/1999 | CN1219390A Novel pharmaceutical composition for control and treatment of anorectal and colonic diseases |
| 06/15/1999 | US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents |
| 06/15/1999 | US5912016 Particles of crosslinked plant proteins and the process for their preparation |
| 06/15/1999 | US5911994 Extract from Salvia officinalis for use in the treatment of Dupuytrens's contracture |
| 06/15/1999 | US5911993 For non-insulin dependent diabetes to lower blood sugar; administering extracts from plants of family crassulaceae, genus sinocressula berger; breaking cell walls of crushed leaves, filtration, form powder from concentrated filtrate |
| 06/15/1999 | US5911992 Suppress appetite, and also acts to induce thermogenesis and inhibit lipogenesis, so as to prevent weight gain, st. john's wort, |
| 06/15/1999 | CA2151888C Topical composition containing an antioxidant and a bacterial extract; use thereof |
| 06/15/1999 | CA2088068C Protein structure of the plant toxin gelonin |
| 06/10/1999 | WO1999027943A1 Use of ginkgo biloba extracts for preparing a medicine |
| 06/10/1999 | WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods |
| 06/10/1999 | WO1999027802A1 HEALTH BEVERAGE CONTAINING THE EXTRACT OF $i(PHELLINUS LINTEUS) |
| 06/10/1999 | WO1999027793A2 An antimicrobial composition |
| 06/10/1999 | CA2312851A1 Therapeutic and diagnostic methods dependent on cyp2a enzymes |
| 06/09/1999 | EP0920872A1 Use of rosmarinus officinalis for treating various diseases |
| 06/09/1999 | EP0920871A1 Process for inhibiting precipitation in fresh press juice from echinacea |
| 06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
| 06/09/1999 | EP0630232B1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 06/08/1999 | US5910317 Mixed compositions for treating hypercholesterolemia |
| 06/08/1999 | US5910308 Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis |
| 06/08/1999 | US5910307 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 06/08/1999 | CA2157749C Plant compound used for the binding of a perfume in a cosmetic and/or dermatologic composition |
| 06/03/1999 | WO1999027136A1 Decreasing cell proliferation by decreasing levels of pp5 |
| 06/03/1999 | WO1999026643A1 Methods of preparation of bioginkgo |
| 06/03/1999 | WO1999026622A1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases |
| 06/03/1999 | CA2309888A1 Decreasing cell proliferation by decreasing levels of pp5 |
| 06/02/1999 | EP0919240A1 Anticancer composition |
| 06/02/1999 | EP0919238A2 Crude drug extract containing soluble silicon |
| 06/02/1999 | EP0918517A1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against parasitary diseases of animals |